A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. (Q51768323)

11 April 2018

title

A common JAK2 haplotype confers susceptibility to myeloproliferative neoplasms. (English)

1 reference

11 April 2018

author

Ashot Harutyunyan

2

1 reference

11 April 2018

Robert Kralovics

8

1 reference

11 April 2018

Ingrid Pabinger

6

object named as

Ingrid Pabinger

1 reference

11 April 2018

Damla Olcaydu

1

1 reference

11 April 2018

Roland Jäger

3

1 reference

11 April 2018

Tiina Berg

4

1 reference

11 April 2018

Bettina Gisslinger

5

1 reference

11 April 2018

Heinz Gisslinger

7

1 reference

11 April 2018

language of work or name

English

0 references

publication date

15 March 2009

1 reference

11 April 2018

published in

Nature Genetics

1 reference

11 April 2018

volume

41

1 reference

11 April 2018

issue

4

1 reference

11 April 2018

page(s)

450-454

1 reference

11 April 2018

https://scigraph.springernature.com/pub.10.1038/ng.341

exact match

0 references

cites work

A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera

1 reference

A gain-of-function mutation of JAK2 in myeloproliferative disorders

21 January 2018

1 reference

Activating mutation in the tyrosine kinase JAK2 in polycythemia vera, essential thrombocythemia, and myeloid metaplasia with myelofibrosis

21 January 2018

1 reference

JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis

21 January 2018

1 reference

MPLW515L is a novel somatic activating mutation in myelofibrosis with myeloid metaplasia

21 January 2018

1 reference

MPL515 mutations in myeloproliferative and other myeloid disorders: a study of 1182 patients

21 January 2018

1 reference

JAK2 stimulates homologous recombination and genetic instability: potential implication in the heterogeneity of myeloproliferative disorders.

21 January 2018

1 reference

Acquisition of the V617F mutation of JAK2 is a late genetic event in a subset of patients with myeloproliferative disorders.

21 January 2018

1 reference

Genetic complexity of myeloproliferative neoplasms.

21 January 2018

1 reference

Lack of mutation at codon 531 of SRC in advanced colorectal cancers from Italian patients

21 January 2018

1 reference

Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations

21 January 2018

1 reference

Familial colorectal cancer in Ashkenazim due to a hypermutable tract in APC.

21 January 2018

1 reference

Common genetic variation in TP53 is associated with lung cancer risk and prognosis in African Americans and somatic mutations in lung tumors

21 January 2018

1 reference

dChipSNP: significance curve and clustering of SNP-array-based loss-of-heterozygosity data

21 January 2018

1 reference

PLINK: a tool set for whole-genome association and population-based linkage analyses

21 January 2018

1 reference

Haploview: analysis and visualization of LD and haplotype maps

21 January 2018

1 reference

Multiple sporadic gastrointestinal stromal tumors (GISTs) of the proximal stomach are caused by different somatic KIT mutations suggesting a field effect

21 January 2018

1 reference

Genetic evidence for an independent origin of multiple preneoplastic and neoplastic lung lesions.

21 January 2018

1 reference

12 December 2020

Host genetic variation contributes to phenotypic diversity in myeloproliferative disorders

1 reference

12 December 2020

p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma

1 reference

12 December 2020

Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders

1 reference

12 December 2020

Multiple K-ras codon 12 mutations in cholangiocarcinomas demonstrated with a sensitive polymerase chain reaction technique.

1 reference

12 December 2020

Identifiers

DOI

10.1038/NG.341

1 reference

11 April 2018

PubMed ID

19287385

1 reference

11 April 2018